Search results
Navidea drops rheumatoid arthritis programme after failed Phase III trial
Pharmaceutical Technology· 11 hours agoIII study (NCT05246280), which enrolled 523 patients, aimed to confirm the ability of intravenous...
III study (NCT05246280), which enrolled 523 patients, aimed to confirm the ability of intravenous...